ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,065Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 680

$1.14M Total Retail Price of All Prescriptions

Rank: 57 out of 680

684 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 684 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

24% of this provider’s 684 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 16,732 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 734 555 S3 1 4
LEVOTHYROXINE SODIUM 659 560 2 2
PRAVASTATIN SODIUM 618 508 3 10
SIMVASTATIN 605 518 4 3
AMLODIPINE BESYLATE 587 492 5 1
LISINOPRIL 475 404 6 5
METFORMIN HCL 447 298 7 8
FUROSEMIDE 429 342 8 6
POTASSIUM CHLORIDE 401 301 9 14
OMEPRAZOLE 384 253 10 7
GABAPENTIN 382 277 11 15
HYDROCHLOROTHIAZIDE 352 282 12 9
METOPROLOL TARTRATE 331 262 13 12
PANTOPRAZOLE SODIUM 324 280 14 30
MELOXICAM 241 217 15 24
BENAZEPRIL HCL 239 171 16 40
WARFARIN SODIUM 235 208 17 20
RISPERIDONE 230 125 18 80
DONEPEZIL HCL 229 206 19 27
PREDNISONE 223 138 20 50
CLOPIDOGREL 212 172 21 26
TAMSULOSIN HCL 212 172 21 34
ALENDRONATE SODIUM 202 182 23 32
ZOLPIDEM TARTRATE 197 145 24 17
CLONIDINE HCL 197 112 24 36
GLIMEPIRIDE 194 127 26 29
BENZTROPINE MESYLATE 186 81 R 27 137
KLOR-CON M20 179 146 28 61
RANITIDINE HCL 179 128 28 56
BUMETANIDE 179 126 28 102
NAMENDA 170 146 31 35
METHYLPREDNISOLONE 169 137 32 93
PLAVIX 159 127 33 39
ALLOPURINOL 157 105 34 33
ISOSORBIDE MONONITRATE ER 156 102 35 59
QUETIAPINE FUMARATE 144 70 36 64
CARVEDILOL 143 114 37 23
METOPROLOL SUCCINATE 142 109 38 13
ATORVASTATIN CALCIUM 142 114 38 11
CRESTOR 139 100 40 25
SERTRALINE HCL 137 109 41 28
NEXIUM 128 106 42 16
NIFEDIPINE ER 127 115 43 75
QUINAPRIL HCL 124 73 44 104
DIOVAN 120 70 45 31
DIVALPROEX SODIUM ER 117 69 46 148
OLANZAPINE 115 42 47 116
CYMBALTA 114 76 48 46
AMITRIPTYLINE HCL 114 95 R 48 47
ESCITALOPRAM OXALATE 113 100 50 45
MEGESTROL ACETATE 110 96 R 51 88
SULFAMETHOXAZOLE-TRIMETHOPRIM 109 89 52 94
TRAMADOL HCL 108 95 53 18
CITALOPRAM HBR 108 79 53 22
LACTULOSE 108 60 53 92
SYNTHROID 101 64 56 38
ENALAPRIL MALEATE 101 88 56 65
CARBINOXAMINE MALEATE 98 87 R 58 317
ATENOLOL 98 65 58 19
HALOPERIDOL 96 28 60 193
PAROXETINE HCL 95 80 61 76
VERAPAMIL ER 95 95 61 100
ADVAIR DISKUS 95 85 61 53
SINGULAIR 88 72 64 91
FLUOXETINE HCL 83 66 65 74
AZITHROMYCIN 81 65 66 42
GLYBURIDE 80 49 R 67 85
CYCLOBENZAPRINE HCL 80 58 R 67 81
DIVALPROEX SODIUM 79 0 69 110
SUCRALFATE 79 72 69 160
METOLAZONE 78 78 71 201
CELEBREX 78 56 71 90
DILTIAZEM 24HR CD 77 77 73 182
LOSARTAN POTASSIUM 77 51 73 21
FAMOTIDINE 77 69 73 89
OXYBUTYNIN CHLORIDE 77 53 73 129
PROMETHAZINE HCL 76 35 R 77 96
VALPROIC ACID 76 49 77 254
TRIAMTERENE-HCTZ 76 58 77 52
PROAIR HFA 75 34 80 67
KLOR-CON 10 74 40 81 184
CLOTRIMAZOLE-BETAMETHASONE 71 58 82 138
INSULIN SYRINGE 69 60 83 86
LANTUS 69 54 83 49
PROPRANOLOL HCL 67 35 85 145
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 56 86 37
BUPROPION HCL SR 66 36 86 250
CIPROFLOXACIN HCL 66 62 86 57
DIGOXIN 64 57 89 58
MIRTAZAPINE 64 52 89 78
LEVEMIR FLEXPEN 64 46 89 186
SPIRONOLACTONE 61 45 92 82
FLUTICASONE PROPIONATE 61 45 92 41
LANTUS SOLOSTAR 60 27 94 84
NABUMETONE 60 54 94 174
TRAZODONE HCL 59 37 96 48
LEVOFLOXACIN 59 48 96 97
SEROQUEL 57 30 98 123
POLYETHYLENE GLYCOL 3350 56 49 99 62
VYTORIN 56 44 99 152
ISOSORBIDE DINITRATE 55 33 101 227
LITHIUM CARBONATE 54 41 102 312
CLONAZEPAM 54 42 102 190
HYDRALAZINE HCL 54 39 102 71
PHENYTOIN SODIUM EXTENDED 53 19 105 115
ETODOLAC 53 53 105 206
BUSPIRONE HCL 53 42 105 144
AMOX TR-POTASSIUM CLAVULANATE 52 38 108 124
FELODIPINE ER 50 46 109 146
BYSTOLIC 50 50 109 79
LYRICA 50 39 109 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.